During the past decade, Breslin Cancer Center at Ingham Regional Medical Center conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 41 clinical trials were completed, i.e. on average, 512.5% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 6 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Breslin Cancer Center at Ingham Regional Medical Center" #1 sponsor was "Children's Oncology Group" with 43 trials, followed by "NSABP Foundation Inc" with 14 trials sponsored, "SWOG Cancer Research Network" with 11 trials sponsored, "Radiation Therapy Oncology Group" with 4 trials sponsored and "Celgene" with 4 trials sponsored. Other sponsors include 15 different institutions and companies that sponsored additional 22 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Breslin Cancer Center at Ingham Regional Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 74 trials as a collaborator, "SWOG Cancer Research Network" with 4 trials as a collaborator, "Cancer and Leukemia Group B" with 3 trials as a collaborator, "Genentech, Inc." with 3 trials as a collaborator and "Hoffmann-La Roche" with 2 trials as a collaborator. Other collaborators include 25 different institutions and companies that were collaborators in the rest 30 trials.

According to Clinical.Site data, the most researched conditions in "Breslin Cancer Center at Ingham Regional Medical Center" are "Breast Cancer" (17 trials), "Leukemia" (8 trials), "Lymphoma" (8 trials), "Sarcoma" (7 trials) and "Neuroblastoma" (6 trials). Many other conditions were trialed in "Breslin Cancer Center at Ingham Regional Medical Center" in a lesser frequency.

Most popular intervention types in "Breslin Cancer Center at Ingham Regional Medical Center" are "Drug" (73 trials), "Biological" (28 trials), "Procedure" (26 trials), "Radiation" (25 trials) and "Other" (19 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (25 trials), "etoposide" (20 trials), "radiation therapy" (17 trials), "vincristine sulfate" (17 trials) and "doxorubicin hydrochloride" (16 trials). Other intervention names were less common.

The vast majority of trials in "Breslin Cancer Center at Ingham Regional Medical Center" are 77 trials for "All" genders, 16 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Breslin Cancer Center at Ingham Regional Medical Center". undefined are not yet recruiting, 2 are recruiting, 10 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 73 completed trials in Breslin Cancer Center at Ingham Regional Medical Center, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Breslin Cancer Center at Ingham Regional Medical Center, 5 "Phase 1" clinical trials were conducted, 26 "Phase 2" clinical trials and 48 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 7 trials that are defined as “Not Applicable".